Related Experiment Video
Updated: Jun 6, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
HbA1c and atrial fibrillation: a cross-sectional study in Japan
Yasuyuki Iguchi1, Kazumi Kimura, Kensaku Shibazaki
1Department of Stroke Medicine, Kawasaki Medical School, Japan. yigu@med.kawasaki-m.ac.jp
Background:
The aim of the present study was to investigate whether the prevalence of atrial fibrillation (AF) is associated with the level of glycated hemoglobin (HbA1c) in Japanese adults in Kurashiki-city.
Methods:
Adult residents (≧ 40 years old) were examined twice, in 2006 and 2007. Electrocardiography was conducted to determine the presence of AF. After categorizing all participants into two groups (HbA1c <6.5% as low group and ≧ 6.5% as high group), factors independently associated with the prevalence of AF were investigated in total cohort, low and high groups using multivariate logistic regression analysis.
Results:
Of the total 52,448 participants (median age, 72 years; range, 65-78 years; 17,980 men), AF prevalence was 2.2% (1161/52,448). After classifying all participants by HbA1c level, the proportion of participants with AF was 2.2% (1073/49,498) in the low group and 3.0% (88/2950) in high group (p=0.005). AF was significantly associated with cardiac disease (OR, 5.78; 95%CI, 5.07-6.58; p<0.001), elevating HbA1c (OR, 1.57; 95%CI, 1.33-1.84; p<0.001), increasing age (OR, 1.40; 95%CI, 1.30-1.51; p<0.001), and male sex (OR, 1.27; 95%CI, 1.10-1.47; p=0.001) in low group and was related to cardiac disease (OR, 4.85; 95%CI, 3.08-7.62; p<0.001) and age (OR, 1.45; 95%CI, 1.09-1.93; p=0.010) in high group. After adjusted age, gender, vascular risk factors, cardiac disease, and eGFR, elevating HbA1c (OR, 1.18; 95%CI, 1.09-1.28; p<0.001) was the factor in association with AF.
Conclusions:
The presence of AF appears to be associated with the level of HbA1c, especially in patients with HbA1c <6.5%.
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Assessment of blood pressure in brachial artery(two-step method)
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies

